scholarly journals Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I

2016 ◽  
Vol 24 (4) ◽  
pp. 719-725 ◽  
Author(s):  
Cristina Martin-Higueras ◽  
Sergio Luis-Lima ◽  
Eduardo Salido
Keyword(s):  
Mouse Model ◽  
Primary Hyperoxaluria ◽  
Substrate Reduction Therapy ◽  
Glycolate Oxidase ◽  
Type I ◽  
Primary Hyperoxaluria Type ◽  
Substrate Reduction ◽  
Hyperoxaluria Type I ◽  
Primary Hyperoxaluria Type I ◽  
Hyperoxaluria Type

scholarly journals CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I

2018 ◽  
Vol 9 (1) ◽  
Author(s):  
Nerea Zabaleta ◽  
Miren Barberia ◽  
Cristina Martin-Higueras ◽  
Natalia Zapata-Linares ◽  
Isabel Betancor ◽  
...  
Keyword(s):  
Primary Hyperoxaluria ◽  
Glycolate Oxidase ◽  
Type I ◽  
Safe Treatment ◽  
Primary Hyperoxaluria Type ◽  
Hyperoxaluria Type I ◽  
Primary Hyperoxaluria Type I ◽  
Hyperoxaluria Type

Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type I

2018 ◽  
Vol 34 (2) ◽  
pp. 319-327 ◽  
Author(s):  
Alexandra Bruel ◽  
Justine Bacchetta ◽  
Tiphanie Ginhoux ◽  
Christelle Rodier-Bonifas ◽  
Anne-Laure Sellier-Leclerc ◽  
...  
Keyword(s):  
Primary Hyperoxaluria ◽  
Microvascular Dysfunction ◽  
Type I ◽  
Primary Hyperoxaluria Type ◽  
Hyperoxaluria Type I ◽  
Primary Hyperoxaluria Type I ◽  
Hyperoxaluria Type

Long-Term Survival on Renal Replacement Therapy for Primary Hyperoxaluria Type I

Nephron ◽  
1993 ◽  
Vol 63 (2) ◽  
pp. 217-221 ◽  
Author(s):  
P. Calzavara ◽  
M. Marangelld ◽  
M. Petrarulo ◽  
P. Ballanti ◽  
E. Bonucci ◽  
...  
Keyword(s):  
Renal Replacement Therapy ◽  
Replacement Therapy ◽  
Primary Hyperoxaluria ◽  
Type I ◽  
Term Survival ◽  
Primary Hyperoxaluria Type ◽  
Hyperoxaluria Type I ◽  
Primary Hyperoxaluria Type I ◽  
Hyperoxaluria Type
Sign in / Sign up

Export Citation Format

Share Document